10-K Filing

CENCORA, INC. CIK: 1140859 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001140859-22-000098`
Period End Date	20220930
Filing Date	20221122
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	abc-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 70 Cash Flow Statement 143 Stockholders Equity 39 Comprehensive Income 21

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Allowances for returns and credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.36B	USD	Point-in-time
Allowances for returns and credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.63B	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.55B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.60B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.39B	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Accounts receivable, less allowances for returns and credit losses: 2022 $1,626,729; 2021 $1,356,684	`AccountsReceivableNetCurrent`	$18.45B	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	292.70M	shares	Point-in-time
Accounts receivable, less allowances for returns and credit losses: 2022 $1,626,729; 2021 $1,356,684	`AccountsReceivableNetCurrent`	$18.17B	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	290.72M	shares	Point-in-time
Inventories	`InventoryNet`	$15.37B	USD	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	206.20M	shares	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	208.09M	shares	Point-in-time
Inventories	`InventoryNet`	$15.56B	USD	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.53B	USD	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	82.63M	shares	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	86.50M	shares	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.27B	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$172.57M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$221.88M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$487.87M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$853.60M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$372.91M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$39.59B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$38.80B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.16B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.14B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Goodwill	`Goodwill`	$8.50B	USD	Point-in-time
Goodwill	`Goodwill`	$9.03B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$4.33B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$5.26B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$237.57M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$290.79M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.79B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.76B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$57.34B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$56.56B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$38.01B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$40.19B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$2.21B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$2.86B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$1.07B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$300.21M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$192.07M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$41.36B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$43.48B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$4.63B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$6.38B	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$320.27M	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$281.07M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.62B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.69B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$976.58M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.08B	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$5.46B	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$5.96B	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value authorized, issued, and outstanding: 2022 600,000,000 shares, 292,700,490 shares and 206,203,817 shares; 2021 600,000,000 shares, 290,722,533 shares and 208,089,298 shares	`CommonStockValue`	$2.91M	USD	Point-in-time
Common stock, $0.01 par value authorized, issued, and outstanding: 2022 600,000,000 shares, 292,700,490 shares and 206,203,817 shares; 2021 600,000,000 shares, 290,722,533 shares and 208,089,298 shares	`CommonStockValue`	$2.93M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.47B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.66B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.67B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.98B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-445.44M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.83B	USD	Point-in-time
Treasury stock, at cost: 2022 86,496,673 shares; 2021 82,633,235 shares	`TreasuryStockValue`	$6.47B	USD	Point-in-time
Treasury stock, at cost: 2022 86,496,673 shares; 2021 82,633,235 shares	`TreasuryStockValue`	$7.02B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' (deficit) equity	`StockholdersEquity`	$-211.56M	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' (deficit) equity	`StockholdersEquity`	$223.35M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$361.06M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$282.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$584.41M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.27M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$57.34B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$56.56B	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$238.59B	USD	Annual
Revenue	`Revenues`	$213.99B	USD	Annual
Revenue	`Revenues`	$189.89B	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$184.70B	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$230.29B	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$207.05B	USD	Annual
Gross profit	`GrossProfit`	$6.94B	USD	Annual
Gross profit	`GrossProfit`	$5.19B	USD	Annual
Gross profit	`GrossProfit`	$8.30B	USD	Annual
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$2.77B	USD	Annual
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$4.85B	USD	Annual
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$3.59B	USD	Annual
Depreciation	`DepreciationNonproduction`	$386.60M	USD	Annual
Depreciation	`DepreciationNonproduction`	$280.19M	USD	Annual
Depreciation	`DepreciationNonproduction`	$326.82M	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$307.30M	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$178.35M	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$110.88M	USD	Annual
Litigation and opioid-related expenses	`LitigationSettlementExpense`	$123.19M	USD	Annual
Litigation and opioid-related expenses	`LitigationSettlementExpense`	$272.62M	USD	Annual
Litigation and opioid-related expenses	`LitigationSettlementExpense`	$6.72B	USD	Annual
Acquisition, integration, and restructuring expenses	`BusinessCombinationAcquisitionIntegrationAndRestructuringExpenses`	$199.29M	USD	Annual
Acquisition, integration, and restructuring expenses	`BusinessCombinationAcquisitionIntegrationAndRestructuringExpenses`	$183.06M	USD	Annual
Acquisition, integration, and restructuring expenses	`BusinessCombinationAcquisitionIntegrationAndRestructuringExpenses`	$84.96M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$75.94M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$6.40M	USD	Point-in-time
Goodwill impairment	`GoodwillImpairmentLoss`	$6.37M	USD	Annual
Impairment of assets	`TangibleAssetImpairmentCharges`	$11.32M	USD	Annual
Impairment of assets	`TangibleAssetImpairmentCharges`	$361.65M	USD	Annual
Impairment of assets	`TangibleAssetImpairmentCharges`	$4.95M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$-5.14B	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$2.35B	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$2.37B	USD	Annual
Other income, net	`NonoperatingIncomeExpense`	$27.35M	USD	Annual
Other income, net	`NonoperatingIncomeExpense`	$41.74M	USD	Annual
Other income, net	`NonoperatingIncomeExpense`	$1.58M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-210.67M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-137.88M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-174.07M	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.29B	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.22B	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.18B	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-1.89B	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$516.52M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$677.25M	USD	Annual
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.67B	USD	Annual
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.16M	USD	Annual
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-32.28M	USD	Annual
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.68M	USD	Annual
Net income (loss) attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$1.70B	USD	Annual
Net income (loss) attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$-3.41B	USD	Annual
Net income (loss) attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$1.54B	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$-16.65	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$8.15	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$7.48	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$-16.65	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$8.04	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$7.39	USD	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	208.47M	shares	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	204.78M	shares	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	205.92M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	211.21M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	208.47M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	204.78M	shares	Annual

Cash Flow Statement 143 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.67B	USD	Annual
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$390.64M	USD	Annual
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$290.74M	USD	Annual
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$326.71M	USD	Annual
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$188.07M	USD	Annual
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$117.27M	USD	Annual
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$319.19M	USD	Annual
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$11.91M	USD	Annual
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$12.10M	USD	Annual
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$26.05M	USD	Annual
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$196.18M	USD	Annual
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.54B	USD	Annual
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$334.87M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$93.40M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$99.59M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$74.41M	USD	Annual
LIFO expense (credit)	`InventoryLIFOReservePeriodCharge`	$7.42M	USD	Annual
LIFO expense (credit)	`InventoryLIFOReservePeriodCharge`	$67.17M	USD	Annual
LIFO expense (credit)	`InventoryLIFOReservePeriodCharge`	$-203.03M	USD	Annual
Impairment of assets, including goodwill	`AssetImpairmentCharges`	$80.88M	USD	Annual
Impairment of assets, including goodwill	`AssetImpairmentCharges`	$31.70M	USD	Annual
Impairment of assets, including goodwill	`AssetImpairmentCharges`	$361.65M	USD	Annual
Gain on sale of businesses	`GainLossOnSaleOfBusiness`	-	USD	Annual
Gain on sale of businesses	`GainLossOnSaleOfBusiness`	$56.23M	USD	Annual
Gain on sale of businesses	`GainLossOnSaleOfBusiness`	-	USD	Annual
Turkey highly inflationary impact	`InflationaryAccountingImpact`	-	USD	Annual
Turkey highly inflationary impact	`InflationaryAccountingImpact`	$51.97M	USD	Annual
Turkey highly inflationary impact	`InflationaryAccountingImpact`	-	USD	Annual
Gain on remeasurement of equity investment	`EquityInvestmentRemeasurementGainLoss`	-	USD	Annual
Gain on remeasurement of equity investment	`EquityInvestmentRemeasurementGainLoss`	$4.83M	USD	Annual
Gain on remeasurement of equity investment	`EquityInvestmentRemeasurementGainLoss`	$64.72M	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-29.36M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-11.78M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$3.04M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.66B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$930.08M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.63B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$665.37M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.62B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.12B	USD	Annual
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$482.57M	USD	Annual
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-49.31M	USD	Annual
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-266.55M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-102.71M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-141.06M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.05M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.30B	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.32B	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.05B	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$524.02M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-457.23M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$372.08M	USD	Annual
Income taxes payable and other liabilities	`IncreaseDecreaseInIncomeTaxesPayableAndOtherLiabilities`	$-330.08M	USD	Annual
Income taxes payable and other liabilities	`IncreaseDecreaseInIncomeTaxesPayableAndOtherLiabilities`	$-50.12M	USD	Annual
Income taxes payable and other liabilities	`IncreaseDecreaseInIncomeTaxesPayableAndOtherLiabilities`	$-178.12M	USD	Annual
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	$-500.19M	USD	Annual
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	$6.20B	USD	Annual
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	$-236.99M	USD	Annual
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$2.21B	USD	Annual
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$2.67B	USD	Annual
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$2.70B	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$438.22M	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$496.32M	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$369.68M	USD	Annual
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$133.81M	USD	Annual
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$5.56B	USD	Annual
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$162.62M	USD	Annual
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$18.49M	USD	Annual
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$56.08M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$6.30M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$36.36M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$14.44M	USD	Annual
Proceeds from sale of businesses	`ProceedsFromDivestitureOfBusinesses`	$272.59M	USD	Annual
Proceeds from sale of businesses	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Proceeds from sale of businesses	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.30M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-7.86M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-9.52M	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-368.44M	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-6.14B	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-379.87M	USD	Annual
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$155.19M	USD	Annual
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$599.48M	USD	Annual
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$3.17B	USD	Annual
Senior notes and other loan repayments	`RepaymentsOfOtherLongTermDebt`	$598.45M	USD	Annual
Senior notes and other loan repayments	`RepaymentsOfOtherLongTermDebt`	$1.24B	USD	Annual
Senior notes and other loan repayments	`RepaymentsOfOtherLongTermDebt`	$835.31M	USD	Annual
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$4.97B	USD	Annual
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$4.83B	USD	Annual
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$116.95M	USD	Annual
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$4.67B	USD	Annual
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$149.98M	USD	Annual
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$5.08B	USD	Annual
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	$21.45M	USD	Annual
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	-	USD	Annual
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	-	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$82.15M	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$420.45M	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$483.70M	USD	Annual
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$159.53M	USD	Annual
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$93.91M	USD	Annual
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$198.75M	USD	Annual
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$391.69M	USD	Annual
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$343.58M	USD	Annual
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$366.65M	USD	Annual
Profarma retail equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Profarma retail equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Profarma retail equity offering	`ProceedsFromIssuanceOfCommonStock`	$66.36M	USD	Annual
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$23.55M	USD	Annual
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$9.79M	USD	Annual
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$38.08M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-10.12M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.24M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$9.89M	USD	Annual
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-603.62M	USD	Annual
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-1.75B	USD	Annual
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$1.95B	USD	Annual
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-3.73M	USD	Annual
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-57.85M	USD	Annual
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Annual
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, INCLUDING CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAndDisposalGroupIncludingDiscontinueOperation`	$-1.53B	USD	Annual
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, INCLUDING CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAndDisposalGroupIncludingDiscontinueOperation`	$524.02M	USD	Annual
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, INCLUDING CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAndDisposalGroupIncludingDiscontinueOperation`	$1.22B	USD	Annual
LESS: INCREASE IN CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`DisposalGroupIncludingDiscontinuedOperationCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	-	USD	Annual
LESS: INCREASE IN CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`DisposalGroupIncludingDiscontinuedOperationCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.75M	USD	Annual
LESS: INCREASE IN CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`DisposalGroupIncludingDiscontinuedOperationCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-610.00K	USD	Annual
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.22B	USD	Annual
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.53B	USD	Annual
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$523.41M	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.59B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.07B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.59B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.07B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Cash dividends (usd per share)	`CommonStockDividendsPerShareCashPaid`	$1.66	USD	Annual
Cash dividends (usd per share)	`CommonStockDividendsPerShareCashPaid`	$1.84	USD	Annual
Cash dividends (usd per share)	`CommonStockDividendsPerShareCashPaid`	$1.76	USD	Annual
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$584.41M	USD	Point-in-time
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.27M	USD	Point-in-time
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.67B	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-334.51M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-8.95M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-1.42B	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$366.65M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$391.69M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$343.58M	USD	Annual
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$159.53M	USD	Annual
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$93.91M	USD	Annual
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$198.75M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$99.59M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$74.41M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$93.40M	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$512.09M	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$82.15M	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$405.69M	USD	Annual
Profarma retail equity offering	`StockIssuedDuringPeriodValueNewIssues`	$66.36M	USD	Annual
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$38.08M	USD	Annual
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$23.55M	USD	Annual
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$9.79M	USD	Annual
Equity consideration issued for acquisition of Alliance Healthcare (Note 2)	`StockIssuedDuringPeriodValueAcquisitions`	$235.14M	USD	Annual
Acquisition of Alliance Healthcare (Note 2)	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$178.26M	USD	Annual
Sale of business	`NoncontrollingInterestDecreaseFromDeconsolidation`	$3.54M	USD	Annual
Other, net	`StockholdersEquityOther`	$1.36M	USD	Annual
Other, net	`StockholdersEquityOther`	$718.00K	USD	Annual
Other, net	`StockholdersEquityOther`	$-239.00K	USD	Annual
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$584.41M	USD	Point-in-time
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.27M	USD	Point-in-time
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time

Comprehensive Income 21 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.67B	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-334.52M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.87M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.43B	USD	Annual
Other, net	`OtherComprehensiveIncomeOtherNetOfTax`	$-1.07M	USD	Annual
Other, net	`OtherComprehensiveIncomeOtherNetOfTax`	$10.00K	USD	Annual
Other, net	`OtherComprehensiveIncomeOtherNetOfTax`	$4.91M	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-334.51M	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-8.95M	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.42B	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$244.71M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.21B	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.41B	USD	Annual
Comprehensive loss (income) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-68.58M	USD	Annual
Comprehensive loss (income) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-2.92M	USD	Annual
Comprehensive loss (income) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$6.78M	USD	Annual
Comprehensive income (loss) income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$1.20B	USD	Annual
Comprehensive income (loss) income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$-3.41B	USD	Annual
Comprehensive income (loss) income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$313.29M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.